BioMarin appoints Ian T. Clark to Board of Directors effective August 1, 2025

BIOMARIN PHARMACEUTICAL INC

Board size increased from ten to eleven members to accommodate Clark's appointment.
Clark appointed to Audit Committee and Science and Technology Committee.
Received RSU grant valued at $400,000 under 2017 Equity Incentive Plan.
Will receive standard non-employee director fees and committee retainers as outlined in proxy statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.